Pretreatment with bacterial components promotes DSS-injured colonic epithelial repair through the activation of STAT-3

Xu,Zhenglei; Liao,Bihong; Zhang,Ru; Sh,Ruiyue; Wang,Lisheng

doi:10.3892/mmr.2017.6812

Pretreatment with bacterial components promotes DSS-injured colonic epithelial repair through the activation of STAT-3

Authors:
- Zhenglei Xu
- Bihong Liao
- Ru Zhang
- Ruiyue Sh
- Lisheng Wang
View Affiliations

Affiliations: Department of Gastroenterology, Second Clinical Medical College, Jinan University, Shenzhen People's Hospital, Shenzhen, Guangdong 510632, P.R. China
Published online on: June 20, 2017 https://doi.org/10.3892/mmr.2017.6812
Pages: 2247-2253

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Bacterial protection and epithelial repair are important against inflammatory bowel disease (IBD). The present study was designed to examine the effects of different bacterial components on the repair of normal and dextran sodium sulfate (DSS)‑treated colonic epithelial cells and the corresponding mechanisms. Human colonic epithelial cells (HT‑29) were pretreated with various doses of LPS or CpG‑dsDNA for 24 h and then treated with or without DSS for another 24 h. The epithelial repair was assessed by video analyses following mechanical injury. The epithelial expression of cluster of differentiation (CD)40 was assayed using flow cytometeric analysis. The production of interleukin (IL)‑6 and tumor necrosis factor (TNF) in the cell culture medium were measured using ELISA. The expression of p38 mitogen‑activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT)‑3 were examined using western blot analysis and reverse transcription‑quantitative polymerase chain reaction analysis. MAPK and STAT‑3 inhibitors were also administrated to observe signaling‑mediated repair. The results showed that pretreatment with lipopolysaccharide (LPS) or CpG‑dsDNA promoted epithelial repair of the DSS‑treated cells. The promoting effects were associated with the downregulation of CD40 molecules, inhibition of the p38 MAPK/TNFα pathway and activation of the STAT3/IL‑6 pathway. The STAT3 inhibitor abrogated the protective effects of LPS and CpG‑dsDNA on wound repair. These results demonstrated that LPS and CpG‑dsDNA induced preadaptation to DSS injury. This preadaptation was accompanied by the activation of STAT‑3. Thus, bacterial components may be used as a strategy for the therapeutic prevention of IBD.

View Figures

View References

1	de Mattos BR, Garcia MP, Nogueira JB, Paiatto LN, Albuquerque CG, Souza CL, Fernandes LG, Tamashiro WM and Simioni PU: Inflammatory bowel disease: An overview of immune mechanisms and biological treatments. Mediators Inflamm. 2015:4930122015. View Article : Google Scholar : PubMed/NCBI
2	Chassaing B, Koren O, Carvalho FA, Ley RE and Gewirtz AT: AIEC pathobiont instigates chronic colitis in susceptible hosts by altering microbiota composition. Gut. 63:1069–1080. 2014. View Article : Google Scholar : PubMed/NCBI
3	Sahay B, Ge Y, Colliou N, Zadeh M, Weiner C, Mila A, Owen JL and Mohamadzadeh M: Advancing the use of Lactobacillus acidophilus surface layer protein A for the treatment of intestinal disorders in humans. Gut Microbes. 6:392–397. 2015. View Article : Google Scholar : PubMed/NCBI
4	Zhu J, Wang Y, Yang F, Sang L, Zhai J, Li S, Li Y, Wang D, Lu C and Sun X: IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response. Int mmunopharmacol. 29:846–853. 2015. View Article : Google Scholar
5	Smyth K, Garcia K, Sun Z, Tuo W and Xiao Z: TLR agonists are highly effective at eliciting functional memory CTLs of effector memory phenotype in peptide immunization. Int Immunopharmacol. 15:67–72. 2013. View Article : Google Scholar : PubMed/NCBI
6	Saito K, Katakura K, Suzuki R, Suzuki T and Ohira H: Modulating Toll-like receptor 4 signaling pathway protects mice from experimental colitis. Fukushima J Med Sci. 59:81–88. 2013. View Article : Google Scholar : PubMed/NCBI
7	Berkowitz D, Peri R, Lavy A and Kessel A: Increased Toll-like receptor 9 expression by B cells from inflammatory bowel disease patients. Hum Immunol. 74:1519–1523. 2013. View Article : Google Scholar : PubMed/NCBI
8	Koguchi Y, Buenafe AC, Thauland TJ, Gardell JL, Bivins-Smith ER, Jacoby DB, Slifka MK and Parker DC: Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4⁺ 8-thymocytes and invariant NKT cells but not in Treg cells. PLoS One. 7:e312962012. View Article : Google Scholar : PubMed/NCBI
9	Iezzi G, Sonderegger I, Ampenberger F, Schmitz N, Marsland BJ and Kopf M: CD40-CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4⁺ T cells. Proc Natl Acad Sci USA. 106:876–881. 2009. View Article : Google Scholar : PubMed/NCBI
10	Senhaji N, Kojok K, Darif Y, Fadainia C and Zaid Y: The contribution of CD40/CD40L axis in inflammatory bowel disease: An update. Front Immunol. 6:5292015. View Article : Google Scholar : PubMed/NCBI
11	Borcherding F, Nitschke M, Hundorfean G, Rupp J, von Smolinski D, Bieber K, van Kooten C, Lehnert H, Fellermann K and Büning J: The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease. Am J Pathol. 176:1816–1827. 2010. View Article : Google Scholar : PubMed/NCBI
12	Arranz A, Reinsch C, Papadakis KA, Dieckmann A, Rauchhaus U, Androulidaki A, Zacharioudaki V, Margioris AN, Tsatsanis C and Panzner S: Treatment of experimental murine colitis with CD40 antisense oligonucleotides delivered in amphoteric liposomes. J Control Release. 165:163–172. 2013. View Article : Google Scholar : PubMed/NCBI
13	Gao D, Wagner AH, Fankhaenel S, Stojanovic T, Schweyer S, Panzner S and Hecker M: CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut. 54:70–77. 2005. View Article : Google Scholar : PubMed/NCBI
14	Lee JW, Wang P, Kattah MG, Youssef S, Steinman L, DeFea K and Straus DS: Differential regulation of chemokines by IL-17 in colonic epithelial cells. J Immunol. 181:6536–6545. 2008. View Article : Google Scholar : PubMed/NCBI
15	Ng HP, Burris RL and Nagarajan S: Attenuated atherosclerotic lesions in apoE-Fcγ-chain-deficient hyperlipidemic mouse model is associated with inhibition of Th17 cells and promotion of regulatory T cells. J Immunol. 187:6082–6093. 2011. View Article : Google Scholar : PubMed/NCBI
16	Tan YR, Qi MM, Qin XQ, Xiang Y, Li X, Wang Y, Qu F, Liu HJ and Zhang JS: Wound repair and proliferation of bronchial epithelial cells enhanced by bombesin receptor subtype 3 activation. Peptides. 27:1852–1858. 2006. View Article : Google Scholar : PubMed/NCBI
17	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
18	Frosali S, Pagliari D, Gambassi G, Landolfi R, Pandolfi F and Cianci R: How the intricate interaction among toll-like receptors, microbiota and intestinal immunity can influence gastrointestinal pathology. J Immunol Res. 2015:4898212015. View Article : Google Scholar : PubMed/NCBI
19	Buttó LF, Schaubeck M and Haller D: Mechanisms of microbe-host interaction in Crohn's disease: Dysbiosis vs. Pathobiont selection. Front Immunol. 6:5552015. View Article : Google Scholar : PubMed/NCBI
20	Wang L, Wu G, Qin X, Ma Q, Zhou Y, Liu S and Tan Y: Expression of nodal on bronchial epithelial cells influenced by lung microbes through DNA methylation modulates the differentiation of T-Helper cells. Cell Physiol Biochem. 37:2012–2022. 2015. View Article : Google Scholar : PubMed/NCBI
21	Greene JA, Portillo JA, Corcino Y Lopez and Subauste CS: CD40-TRAF signaling upregulates CX3CL1 and TNF-α in human aortic endothelial cells but not in retinal endothelial cells. PLoS One. 10:e01441332015. View Article : Google Scholar : PubMed/NCBI
22	Wang W, Bai L, Qiao H, Lu Y, Yang L, Zhang J, Lin R, Ren F, Zhang J and Ji M: The protective effect of fenofibrate against TNF-α-induced CD40 expression through SIRT1-mediated deacetylation of NF-κB in endothelial cells. Inflammation. 37:177–185. 2014. View Article : Google Scholar : PubMed/NCBI
23	Seibold K and Ehrenschwender M: p62 regulates CD40-mediated NFκB activation in macrophages through interaction with TRAF6. Biochem Biophys Res Commun. 464:330–335. 2015. View Article : Google Scholar : PubMed/NCBI
24	Chakraborty S, Srivastava A, Jha MK, Nair A, Pandey SP, Srivastava N, Kumari S, Singh S, Krishnasastry MV and Saha B: Inhibition of CD40-induced N-Ras activation reduces leishmania major infection. J Immunol. 194:3852–3860. 2015. View Article : Google Scholar : PubMed/NCBI